Pravastatin-loaded chitosan nanoparticles: Formulation, characterization and cytotoxicity studies

Journal of Drug Delivery Science and Technology

Volumn 32, Issue , 2016, Pages 1-9

  Badran, Mohamed M ^a,b   Harisa, Gamaleldin I ^a,b   Alqahtani, Saeed A ^a   Alanazi, Fars K ^a   Zoheir, Khairy M A ^a,c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Al Azhar University   (Egypt)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Characterization; Chitosan nanoparticles; Cytotoxicity; In vitro release; Pravastatin

Indexed keywords

CHITOSAN NANOPARTICLE; PRAVASTATIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISPERSION; DRUG FORMULATION; DRUG RELEASE; FREEZE DRYING; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; KINETICS; MODEL; MORPHOLOGY; PARTICLE SIZE; POLYDISPERSITY INDEX; SCANNING ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION; ZETA POTENTIAL;

EID: 84960911562     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2016.01.004     Document Type: Article

References (45)

1. M. Abdel Mouez, N.M. Zaki, S. Mansour, and A.S. Geneidi Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres Eur. J. Pharm. Sci. 51 2014 59 66
2. M. Abdel-Hamid, M.F. Ibrahim, G.I. Harisa, and F.K. Alanazi ultra performance liquid chromatography determination of pravastatin sodium in erythrocytes Asian J. Chem. 24 2 2012 584
3. A. Anitha, S. Sowmya, P.T. Sudheesh, S. Deepthi, K.P. Chennazhi, H. Ehrlich, M. Tsurkan, and R. Jayakumar Chitin and chitosan in selected biomedical applications Prog. Polym. Sci. 39 2014 1644 1667
4. A. Azadi, M. Hamidi, and M.R. Rouini Methotrexate-loaded chitosan nanogels as 'Trojan Horses' for drug delivery to brain: preparation and in vitro/in vivo characterization Int. J. Biol. Macromol. 62 2013 523 530
5. E. Bahreini, K. Aghaiypour, R. Abbasalipourkabir, A.R. Mokarram, M.T. Goodarzi, and M. Saidijam Preparation and nanoencapsulation of l-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study Nanoscale Res. Lett. 9 2014 340
6. N. Bhattarai, J. Gunn, and M. Zhang Chitosan-based hydrogels for controlled, localized drug delivery Adv. Drug Deliv. Rev. 62 2010 83 99
7. M. Coimbra, M. Banciu, M.H. Fens, L. de Smet, M. Cabaj, J.M. Metselaar, G. Storm, and R.M. Schiffelers Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation J. Control. Release 148 2010 303 310
8. N.M. Dand, P.B. Patel, A.P. Ayre, and V.J. Kadam Polymeric micelles as a drug carrier for tumor targeting chronicles of young scientists 4 2013 94 101
9. S. Dash, P.N. Murthy, L. Nath, and P. Chowdhury Kinetic modeling on drug release from controlled drug delivery systems Acta Pol. Pharm. 67 2010 217 223
10. N. Deepa, R. Jayakumar, and K.P. Chennazhi Versatile carboxymethyl chitin and chitosan nanomaterials: a review WIREs Nanomed. Nanobiotechnol. 6 2014 574 598
11. J. Ding, C. Xiao, C. He, M. Li, D. Li, X. Zhuang, and X. Chen Facile preparation of a cationic poly(amino acid) vesicle for potential drug and gene co-delivery Nanotechnology 22 2011 1 9
12. Y.1. Dong, W.K. Ng, S. Shen, S. Kim, and R.B. Tan Scalable ionic gelation synthesis of chitosan nanoparticles for drug delivery in static mixers Carbohydr. Polym. 94 2 2013 940 945
13. W. Fan, W. Yan, Z. Xu, and H. Ni Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique Coll. Surf. B Biointerfaces 90 2012 21 27
14. E. Fröhlich The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles Int. J. Nanomed. 7 2012 5577 5591
15. M.U. Ghori, G. Ginting, and A.M. Smith Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices Int. J. Pharm. 465 2014 405 412
16. H. Graf, C. Jüngst, G. Straub, S. Dogan, R.T. Hoffmann, and T. Jakobs Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma Digestion 78 2008 34 38
17. M. Hamidi, A. Azadi, and P. Rafiei Hydrogel Nanoparticles Drug Deliv. 60 2008 1638 1649
18. M. Hamidi, P. Rafiei, A. Azadi, and S. Mohammadi-Samani Encapsulation of valproate-loaded hydrogel nanoparticles in intact human erythrocytes: a novel nano-cell composite for drug delivery J. Pharm. Sci. 100 2010 1702 1711
19. G.I. Harisa, M.B. Mohamed, A.A. Saeed, K.A. Fars, and M.A. Sabry Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer Saudi Pharm. J. 24 2016 74 81
20. Lu Huading, L.v. Lulu, D. Yuhu, Wu Gang, Z. Huiqing, and Z. Fucheng Porous chitosan scaffolds with embedded Hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation PLoS One 8 7 2013 e69950
21. Y. Kangde, L. Junjie, Y. Fanglian, and Y. Yuji Chitosan-based Hydrogels: Functions and Applications 2012 CRC Press Taylor&Francis group USA 154 170
22. M.S. Katz Therapy insight: potential of statins for cancer chemoprevention and therapy Nat. Clin. Pract. Oncol. 2 2005 82 89
23. S. Kawata, E. Yamasaki, T. Nagase, Y. Inui, N. Ito, and Y. Matsuda Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomised controlled trial Br. J. Cancer 84 2001 886 891
24. K.T. Kivisto, and M. Niemi Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans Pharm. Res. 24 2 2007 239 247
25. D.W. Lee, K. Powers, and R. Baney Physicochemical properties and blood compatibility of acylated chitosan nanoparticles Carbohydr. Polym. 58 2004 371 377
26. J. Lee, I. Lee, B. Han, J.O. Park, J. Jang, C. Park, and W.K. Kang Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations J. Natl. Cancer Inst. 103 8 2011 674 688
27. Q. Lifeng, and X. Zirong In vivo antitumor activity of chitosan nanoparticles Bioorg. Med. Chem. Lett. 16 2006 4243 4245
28. Marta Benito-Miguel, M Dolores Blanco, and Clara Gómez Assessment of sequential combination of 5-fluorouracil-loaded-chitosan-nanoparticles and ALA-photodynamic therapy on HeLa cell line Photodiagnosis Photodyn. Ther. 12 2015 466 475
29. D.G. Menter, V.P. Ramsauer, S. Harirforoosh, K. Chakraborty, P. Yang, L. his, R.A. Newman, and K. Krishnan Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites PLoS One 6 12 2011 e28813
30. M.I. Mohammed, H.A. Abd-Elgawad, A.S. Osama, and M.J. Monica Natural bioadhesive biodegradable nanoparticles-based topical ophthalmic formulations for sustained celecoxib release: in vitro study J. Pharm. Technol. Drug Res. 2013 10.7243/2050-120X-2-7
31. V.M. Montori, J.P. Brito, and H.H. Ting Patient-centered and practical application of new high cholesterol guidelines to prevent cardiovascular disease J. Am. Med. Assoc. 311 2014 465 466
32. M. Prabaharan Chitosan-based nanoparticles for tumor-targeted drug delivery Int. J. Biol. Macromol. 72C 2015 1313 1322
33. R.H. Prabhu, V. Patravale, and M.D. Joshi Polymeric nanoparticles for targeted treatment in oncology: current insights Int. J. Nanomed. 5 2015 161 171
34. M. Ramezani, M. Khoshhamdam, A. Dehshahri, and B. Malaekeh-Nikouei The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes Coll. Surf. B Biointerfaces 72 2009 1 5
35. M.K. Riekes, F.M. Barboza, and D.D. Vecchia Evaluation of oral carvedilol microparticles prepared by simple emulsion technique using poly (3-hydroxybutyrate-co-3- hydroxyvalerate) and polycaprolactone as polymers Mater. Sci. Eng. C 31 2011 962 968
36. B. Smith, and H. Land Anticancer activity of the cholesterol exporter ABCA1 gene Cell Rep. 27 3 2012 580 590
37. S. Sultana, M.R. Khan, M. Kumar, S. Kumar, and M. Ali Nanoparticles-mediated drug delivery approaches for cancer targeting: a review J. Drug Target. 21 2013 107 125
38. A. Trapani, E. De Giglio, D. Cafagna, N. Denora, G. Agrimi, T. Cassano, S. Gaetani, V. Cuomo, and G. Trapani Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery Int. J. Pharm. 419 2011 296 307
39. S. Tummala, M.N. Satish Kumar, and P. Ashwati Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer Saudi Pharm. J. 23 2015 308 314
40. B. Wilson, M.K. Samanta, K. Santhi, K.P.S. Kumar, M. Ramasamy, and B. Suresh Chitosan nanoparticlesasa new delivery system for the anti-Alzheimer drug tacrine Nanomed. Nanotechnol. Biol. Med. 6 2010 144 152
41. W.W. Wong, J. Dimitroulakos, M.D. Minden, and L.Z. Penn HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 16 2002 508 519
42. W. Xia, L. Ping, Z. Jiali, and C. Jie Biological activities of chitosan and chitooligosaccharides Food Hydrocoll. 25 2011 170 179
43. K. Yokoi, T. Tanei, B. Godin, A.L. van de Ven, M. Hanibuchi, A. Matsunoki, J. Alexander, and M. Ferrari Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments Cancer Lett. 345 2014 48 55
44. N.M. Zaki, and M.M. Hafez Enhanced antibacterial effect of ceftriaxone sodium-loaded chitosan nanoparticles against intracellular Salmonella typhimurium AAPS Pharm. Sci. Tech. 13 2012 411 421
45. S.H. Zhou, Y. Hong, and G.J. Fang Preparation, characterization and anticancer effect of chitosan nanoparticles J. Clin. Rehabil. Tissue Eng. Res. 11 2007 9688 9691